ANN ARBOR, Mich., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that the company will present at the Jefferies Global Healthcare Conference – London on November 18, 2025, at 8:00 a.m. GMT (3:00 a.m. ET). The live webcast can be accessed on the investor and media section of the Esperion website. Access to the webcast replay will be available approximately two hours after the completion of the call and will be archived on the Company’s website for approximately 90 days. Esperion Th ...

– Leading Cardiovascular Physician Experts to Explore Real-World Challenges and Impact on Patient Outcomes – ANN ARBOR, Mich., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced it will host a virtual key opinion leader (KOL) event for investors to discuss the clinical and real-world challenges of statin intolerance, its impact on patient outcomes, and the Company’s continued commitment to addressing this significant unmet need. The event will be led by LeAnne Bloedon, VP, Head of Cli ...

ANN ARBOR, Mich., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that an oral presentation and a poster presentation have been accepted for presentation at the AHA Scientific Sessions 2025 in New Orleans, LA, November 7-10, 2025. Oral Presentation Bempedoic acid monotherapy, LDL cholesterol, and cardiovascular events: a secondary analysis of the CLEAR Outcomes trialNovember 9, 2025, 9:45 – 11:00 AM CSTPresenter: Carolina Pires Zingano, MD (Cleveland Clinic) Poster PresentationEffe ...

ANN ARBOR, Mich., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced it will report third quarter 2025 financial results before the market opens on Thursday, November 6, 2025. Following the release, management will host a webcast at 8:00 a.m. ET to discuss these financial results and provide business updates. A live audio webcast can be accessed on the investor and media section of the Esperion website. Access to the webcast replay will be available approximately two hours after compl ...

Key Takeaways Esperion named ESP-2001 its new preclinical candidate for primary sclerosing cholangitis.ESP-2001 was discovered with Evotec and has shown liver injury reduction in preclinical studies.Esperion will hold exclusive global rights to develop and commercialize ESP-2001.Esperion Therapeutics (ESPR) announced that it has nominated ESP-2001, a highly specific allosteric ATP citrate lyase (“ACLY”) inhibitor, as its new preclinical development candidate for the treatment of primary sclerosing cholangit ...

– Highly-Specific Allosteric ACLY Inhibitor Designed to Target Liver and Bile Duct Injury, Inflammation, and Fibrosis Associated with Primary Sclerosing Cholangitis (PSC) and Related Diseases – – ESP-2001 Has the Potential to Meaningfully Impact the Progression of PSC, a Disease with No Approved Treatments – ANN ARBOR, Mich., Oct. 16, 2025 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced the nomination of ESP-2001, the Company’s highly-specific allosteric ATP citrate lyase (ACLY) inhibitor, as pr ...

Key Takeaways Esperion priced a 30M-share offering at $2.50, expecting $75M in gross proceeds.ESPR shares fell 17% as investors reacted to the discounted pricing of the new issue.Proceeds will fund Nexletol, Nexlizet expansion, pipeline work and general corporate needs.Esperion Therapeutics (ESPR) recently announced that it is floating a secondary issue of 30 million shares of its common stock to the public at an issue price of $2.50 per share. The company expects to raise approximately $75 million in gross ...

美股市场表现 - 道琼斯指数上涨0.32%至46,751.12点，纳斯达克指数上涨0.88%至22,989.73点，标普500指数上涨0.57%至6,752.93点 [1] - 信息技术板块领涨，涨幅达1.1%，必需消费品板块下跌0.4% [1] 商品市场动态 - 原油价格上涨1.7%至每桶62.78美元，黄金价格上涨1.5%至每盎司4,066.00美元 [5] - 白银价格上涨2.7%至每盎司48.780美元，铜价下跌0.2%至每磅5.0860美元 [5] - 美国原油库存当周增加371.5万桶，远超市场预期的225万桶增幅 [2][11] 全球股市概况 - 欧洲股市普遍上涨，欧元区STOXX 600指数上涨0.86%，德国DAX 40指数上涨0.97%，法国CAC 40指数上涨1.18% [6] - 亚洲市场普遍收跌，日本日经225指数下跌0.45%，香港恒生指数下跌0.48%，印度Sensex指数下跌0.19% [7] 个股异动情况 - 戴尔科技股价大涨9%至163.88美元，多家机构上调其目标价 [9] - Critical Metals Corp 股价飙升15%至11.50美元，公司与REalloys签署为期10年的承购协议 [9] - Select Medical Holdings 股价上涨13%至14.71美元，RBC Capital将其目标价从16美元上调至20美元 [9] - Esperion Therapeutics 股价暴跌19%至2.4912美元，公司宣布以每股2.50美元的价格增发3000万股股票 [9] - Zeta Network Group 股价重挫47%至1.81美元，公司宣布以每股1.00美元的价格定向增发1500万股股票 [9] - Envoy Medical 股价下跌38%至0.9899美元，公司宣布进行400万美元的定向增发和私募配售 [9]

文章核心观点 - 美国股指期货今日早盘小幅上涨 道指期货上涨约0.1% [1] - Penguin Solutions公司因季度营收未达预期且公布未来财年业绩指引 股价在盘前交易中大幅下跌17.6% [1][2] - 多家生物制药、新能源及航空科技公司在盘前交易中因融资活动等因素股价出现显著下跌 [4] Penguin Solutions Inc 第四季度业绩 - 季度每股收益为0.43美元 超出分析师普遍预期的0.38美元 [1] - 季度销售额为3.37922亿美元 低于分析师普遍预期的3.42112亿美元 [1] - 公司公布2026财年调整后每股收益指引为1.75至2.25美元 [2] - 公司公布2026财年销售额指引为13.14亿至15.88亿美元 [2] - 公司股价在盘前交易中下跌17.6%至22.24美元 [2] 其他盘前股价下跌显著的股票 - Esperion Therapeutics公司股价下跌20.1%至2.47美元 原因在于公司宣布了普通股公开发行的定价 [4] - NOVONIX公司股价下跌12.7%至1.79美元 此前一个交易日该股上涨了14% [4] - NANO Nuclear Energy公司股价下跌9.1%至51.50美元 公司宣布完成4亿美元超额认购的普通股私募配售 [4] - Joby Aviation公司股价下跌8.5%至17.30美元 公司以每股16.85美元的价格承销发行3050万股普通股 融资约5.139亿美元 旨在加速电动垂直起降机队的生产和商业部署 [4] - Archer Aviation公司股价下跌4.1%至11.95美元 此前一个交易日该股跌幅超过8% [4] - NextNRG公司股价下跌3.2%至2.73美元 此前一个交易日因公司在佛罗里达州迈尔斯堡推出移动加油业务 股价上涨36% [4] - NuCana公司股价下跌3%至6.81美元 [4]

U.S. stock futures were slightly higher this morning, with the Dow futures gaining around 0.1% on Wednesday.Shares of Penguin Solutions, Inc. (NASDAQ:PENG) fell sharply in today's pre-market trading following fourth-quarter results.Penguin Solutions reported quarterly earnings of 43 cents per share which beat the analyst consensus estimate of 38 cents per share. The company reported quarterly sales of $337.922 million which missed the analyst consensus estimate of $342.112 million.The company also said it s ...